BARD1 Gene Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) (NCT02993068) | M.D. Anderson Cancer Center | 2017-04-18 |
| Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer (NCT03377556) | SWOG Cancer Research Network | 2017-03-03 |
Track BARD1 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.